pyrazolo(3,4-d)pyrimidine has been researched along with Disease Models, Animal in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel Latif, NS; El-Kalaawy, AM; Lamie, PF; Philoppes, JN; Rashed, LA | 1 |
| Abd-El-Aziz, AS; Abdelghani, AA; Al Sorkhy, M; Al-Harbi, KB; Almundarij, TI; Alrawashdeh, S; Atatreh, N; El-Ashmawy, IM; Ghattas, MA; Youssef, AM | 1 |
| Blum, E; Buhl, T; Di Padova, FE; Feifel, R; Gram, H; Hiestand, P; Manning, U; Neumann, U; Revesz, L; Rucklin, G | 1 |
3 other study(ies) available for pyrazolo(3,4-d)pyrimidine and Disease Models, Animal
| Article | Year |
|---|---|
Pyrazolo[3,4-d]pyrimidine-based dual EGFR T790M/HER2 inhibitors: Design, synthesis, structure-activity relationship and biological activity as potential antitumor and anticonvulsant agents.
Topics: Animals; Anticonvulsants; Antineoplastic Agents; Apoptosis; Cell Line; Cell Proliferation; Cell Survival; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; ErbB Receptors; Humans; Lithium Carbonate; Male; Mice; Molecular Structure; Pilocarpine; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Receptor, ErbB-2; Status Epilepticus; Structure-Activity Relationship | 2021 |
Anti-inflammatory drug approach: Synthesis and biological evaluation of novel pyrazolo[3,4-d]pyrimidine compounds.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Edema; Granuloma; Humans; Inflammation; Male; Molecular Docking Simulation; Molecular Structure; Pyrazoles; Pyrimidines; Rats; Rats, Wistar; Recombinant Proteins; Structure-Activity Relationship; Turpentine | 2019 |
Pyrazoloheteroaryls: novel p38alpha MAP kinase inhibiting scaffolds with oral activity.
Topics: Administration, Oral; Animals; Arthritis, Experimental; Disease Models, Animal; Enzyme Inhibitors; Lipopolysaccharides; Mice; Mitogen-Activated Protein Kinase 14; Molecular Structure; Pyrazines; Pyrazoles; Pyridines; Pyrimidines; Rats; Structure-Activity Relationship; Tumor Necrosis Factor-alpha | 2006 |